エピレプシー病の分類:世界疾患のオントロジーを強化するためのコミュニティの取り組み
Nicole Vasilevsky1, Sarah Gehrke2, Kathleen Mullen2
1Critical Path Institute, 1840 E River Rd, Suite 100 Tucson, AZ 85718-5960, United States.
Database : the journal of biological databases and curation
|February 16, 2026
まとめ
稀有性エピレプシは,診断と研究の課題を提示します. 国際抗連盟 (ILAE) の分類に準拠したMondo Disease Ontology (Mondo) の更新は,のデータの標準化と希少疾患の研究を改善します.
科学分野:
- バイオメディカル・インフォマティクス
- 神経学 神経学とは
- 遺伝学 遺伝学とは
背景:
- エピレプシは世界中で5000万人以上に影響を及ぼし,まれな形態は診断と研究に重大な障害をもたらします.
- 正確な疾患分類は,データ共有,臨床的決定,および希少性の研究の進展にとって極めて重要です.
研究 の 目的:
- Mondo Disease Ontology (Mondo) のエピレプシー関連疾患の概念の正確性と相互運用性を向上させる.
- モンドのの分類を,国際抗連盟 (ILAE) システムと整合させる.
主な方法:
- エピレプト学者,遺伝学者,神経発達専門医,患者擁護者など,専門家が参加したワークショップを開催しました.
- 世界における症の階層の体系的な見直しと修正.
- モンドーの分類は,国際病連合 (ILAE) の分類と一致している.
主要な成果:
- 強化されたMondo Disease Ontology (Mondo) で,より細かく,標準化され,臨床的に関連したエピレプシー構造.
- エピレプシーのサブタイプ,症候群,年齢関連のエピレプシー,発達性エピレプシー脳症候群を含む再分類.
- 資源全体にエピレプシーデータを統合するための枠組みを改善し,まれな疾患の研究の相互運用性を強化します.
結論:
- 更新されたMondoオントロジーは,のデータ統合と希少疾患の研究のための堅固な枠組みを提供します.
- モンドの継続的な改良は,臨床的意思決定とエピレプシーのデータキュレーションにおけるその有用性をさらに高めます.
関連する概念動画
01:13Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
01:24Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
01:17Classification of Illness
8.9K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.9K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
957
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
957
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.0K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K